CleanSlate Stock

cleanslatecenters.comHealthcareFounded: 1900Funding to Date: $79.02MM

CleanSlate is a national medical group that provides treatment for the chronic disease of addiction using an integrated approach combining medication-assisted treatment, primary care services and behavioral health therapies to treat polysubstance use disorder and associated co-occurring disorders.

Register for Details

For more details on financing and valuation for CleanSlate, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Gregory Marotta
President, Board Member & Chief Executive Officer
Adam McPhee
Chief Operating Officer
Anthony Belott
Chief Development Officer
Bob Wilson
Chief Human Resources Officer
Paul Chabot
Chief Information Officer
Neil Kunkel JD
Chief Legal Officer
Amanda Wilson MD
Founder & Chairwoman
Tracey Cohen MD
Chief Clinical Officer
Robert Hutchison
Chief Financial Officer

Board Members

Amanda Wilson MD
Christopher Jedrey Ph.D
Diane Daych
Granite Growth Health Partners
Eugene Fleming
Garheng Kong MD
HealthQuest Capital
Jared Teo
HealthQuest Capital
Mark Brooks
Granite Growth Health Partners
Patrick Kennedy
Paul Brown JD

Other companies like CleanSlate in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$2.51B
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$453MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$8.18B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$355.29MM
Sector
Last Round Est. Valuation
$263MM

News

A substance abuse treatment company and its former owner, Dr. Amanda L. Wilson, wrongly charged MassHealth millions of dollars for urine tests patients did not need, Attorney General Maura Healey alleges in a new federal lawsuit.
CleanSlate UV, a Toronto, Canada and Buffalo, NY-based infection control startup offering a hospital-grade, chemical-free sanitizer for mobile devices, raised US$7m in initial close of a new financing round
National leader in outpatient pharmacological treatment for the chronic disease of addiction announces $25 million in financing to accelerate growth.